Bg pattern

MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information: Summary of Product Characteristics

Mebeverina Tarbis 135 mg film-coated tablets EFG

mebeverine hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Mebeverina Tarbis is and what it is used for
  2. What you need to know before you take Mebeverina Tarbis
  3. How to take Mebeverina Tarbis
  4. Possible side effects
  5. Storage of Mebeverina Tarbis
  6. Contents of the pack and other information

1. What Mebeverina Tarbis is and what it is used for

Mebeverina 135 mg film-coated tablets contain the active substance mebeverine hydrochloride, which belongs to a group of medicines called antispasmodics, which act on the intestine.

This medicine is used to relieve the symptoms of irritable bowel syndrome (IBS) and other similar conditions such as irritable colon in adults.

Irritable bowel syndrome (IBS) is a very common condition that causes spasms and pain in the intestine.

The intestine is a long muscular tube through which food passes to be digested. If a spasm occurs in the intestine and the pressure is too strong, it causes pain.

The symptoms vary from person to person, but may include:

  • stomach pain and colic
  • feeling of abdominal distension and gas
  • diarrhea, constipation, or a combination of both

small, hard, fragmented, or pellet-like stools

Your diet and lifestyle can also help treat irritable bowel syndrome (IBS):

A high-fiber diet may be helpful, but consult your doctor or pharmacist for more information.

Relaxation can help reduce IBS symptoms.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Mebeverina Tarbis

Do not take Mebeverina

  • If you are allergic to mebeverine hydrochloride or any of the other ingredients of this medicine (listed in section 6).

If you have intestinal obstruction (paralytic ileus)

Warnings and precautions

Consult your doctor or pharmacist before starting to take this medicine.

If you develop new symptoms or if your symptoms worsen

Other medicines and Mebeverina Tarbis

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Mebeverine is not recommended during pregnancy or breastfeeding.

Driving and using machines

This medicine is unlikely to affect your ability to drive or use tools or machines.

Mebeverina Tarbis contains lactose

Each film-coated tablet contains 97 mg of lactose (as lactose monohydrate).

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Mebeverina Tarbis contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".

3. How to take Mebeverina Tarbis

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Taking this medicine

  • Mebeverine is indicated in adults
  • Take the tablet whole, without dividing it into smaller pieces or chewing it, with a full glass of water, approximately 20 minutes before meals.
  • Try to take your tablets at the same time each day. This will help you remember when to take them.

Use in adults

The recommended dose is one tablet (135 mg of mebeverine hydrochloride) 3 times a day. Do not take more than 3 tablets per day and space the doses evenly throughout the day.

Use in children and adolescents

This medicine is not recommended for use in children and adolescents under 18 years, as there are not enough data available.

If you take more Mebeverina Tarbis than you should

If you have taken more mebeverine than you should or have accidentally ingested the contents of the pack, consult your doctor or pharmacist immediately or contact the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested. It is recommended to take the pack and the leaflet of the medicine to the healthcare professional.

If you forget to take Mebeverina Tarbis

Do not take a double dose to make up for forgotten doses.

If you stop taking Mebeverina Tarbis

Do not stop taking this medicine without consulting your doctor, even if you feel better.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking this medicine and consult a doctor immediately if you experience any of the following serious side effects, as you may need urgent medical treatment:

  • Difficulty breathing, swelling of the face, neck, lips, tongue, or throat. You may be experiencing a severe allergic reaction (hypersensitivity) to this medicine.

Other side effects are:

  • You may experience a milder allergic reaction (hypersensitivity) to the medicine: for example, skin rash, redness, and itching.
  • Very rare cases of dizziness, drowsiness, confusion, and nausea have been reported.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Mebeverina Tarbis

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the pack after "EXP". The expiry date is the last day of the month shown.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Mebeverina Tarbis

The active substance is mebeverine hydrochloride.

Each film-coated tablet contains 135 mg of mebeverine hydrochloride.

The other excipients are:

Core of the tablet: lactose monohydrate, microcrystalline cellulose, sodium starch glycolate (type A, potato), povidone, talc, magnesium stearate

Coating of the tablet: hypromellose, macrogol, titanium dioxide

Appearance of the product and contents of the pack

White, round, biconvex, and smooth film-coated tablets on both sides.

Diameter: 10.0 mm and thickness: 4.3 mm

Mebeverina Tarbis 135 mg film-coated tablets EFG are available in Al/PVC and PVC/PVDC-aluminum blisters in packs of 60 tablets.

Marketing authorization holder

Tarbis Farma S.L.

Gran Vía Carlos III, 94

08028 Barcelona

Spain

Manufacturer

Amarox Pharma B.V

Rouboslaan 32, Voorschoten,

2252TR Netherlands

Or

Meiji Pharma Spain S.A.

Avda. de Madrid 94 – Alcalá de Henares

28802 – Spain

Date of last revision of this leaflet: May 2025

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

Online doctors for MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS

Discuss questions about MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (34)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
The active ingredient in MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS is mebeverine. This information helps identify medicines with the same composition but different brand names.
Who manufactures MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS is manufactured by Tarbis Farma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MEBEVERINE TARBIS 135 mg FILM-COATED TABLETS?
Other medicines with the same active substance (mebeverine) include DUSPATALIN 135 mg FILM-COATED TABLETS, AERO RED 40 mg CHEWABLE TABLETS, AERO-RED 120 mg CHEWABLE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media